A major discovery in cancer investigation is emerging with the use of nanobodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently lost in many kinds of malignancies, resulting https://hindibookmark.com/story24043318/mini-antibodies-revive-the-p53-protein-a-promising-hope-for-tumor-management